Navigation Links
Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness

Multiple-genotype infections are increasingly recognized as important factors in disease evolution, parasite transmission dynamics, and the evolution of drug resistance. However, the distinction of co-infecting site genotypes and the tracking of their dynamics have been // ficult with traditional methods based on various genotyping techniques, leaving most questions unaddressed.

Trypanosoma brucei , a protozoan parasite transmitted by the bite of the tsetse fly (Glossina spp.), is of great medical and economic interest in Africa. It causes human sleeping sickness, and Nagana, a cattle disease that prevents cattle farming and the use of work animals over huge areas of sub-Saharan Africa, thus profoundly affecting the economics of the entire continent.

A recent study, to be published in Acta Tropica (available online 4 October 2005) reports new fluorescence markers of various colours that are inserted into the genome of T. brucei to phenotypically label live parasites of all life cycle stages. If different parasite strains are labelled with different colours they can be easily distinguished from each other in experimental studies.

For the study, a total of 10 T. brucei strains were successfully transfected with different fluorescence markers and were monitored in culture, tsetse flies and mice, to demonstrate stability of marker _expression.

The use of fluorescence activated cell sorting (FACS) allowed rapid and accurate identification of parasite strains labelled with different markers. Cell counts by FACS were virtually identical to counts by traditional microscopy but were considerably faster and had a significantly lower sampling error . Co-infecting strains transfected with fluorescence genes of different colour were easily distinguished by eye and their relative and absolute densities were reliably counted by FACS in experimental multiple infections in mice.

Since the FACS can simultaneously determine th e population sizes of differently labelled T. brucei strains or subspecies it allows detailed and efficient tracking of multiple-genotype infections within a single host or vector individual, enabling more powerful studies on parasite dynamics. In addition, it also provides a simple way to separate genotypes after experimental mixed infections, to measure responses of the single strains to an applied treatment, thus eliminating the need for laborious cloning steps.

The markers presented in this study broaden the spectrum of tools available for experimental studies on multiple-genotype infections. They are fundamentally different from isoenzyme analysis and other genotyping approaches in that they allow the distinction of parasite genotypes based on an easily recognizable phenotypic trait.

The authors conclude that the distinction of live parasites based on an easily recognized phenotypic trait and the physical separation of genotypes from mixed infections made possible by live fluorescence markers make trypanosomes an attractive system for experimental studies on parasite population dynamics. The marker described in this study will be especially important by opening new avenues of research on the ecology and evolution of mixed trypanosome infections and their implications for disease dynamics and control. The authors assert that they will be of specific interest to researches addressing ecological, evolutionary and epidemiological questions using trypanosomes as an experimental system.

Related medicine news :

1. Scientific markers of aging described
2. Molecular markers for early diagnosis of breast and ovarian cancer
3. Biomarkers May Indicate Alzheimers Disease
4. Biomarkers Could Prove Significant In Understanding Aging Process
5. Researchers Find Mix of Biomarkers Predicting Mortality
6. Biomarkers Predicting Mortality Found Using Statistical Technique
7. Biomarkers Found Harmful For Human Lupus
8. Researchers Find Two Biomarkers With Potential to Predict Breast Cancer Spread
9. Biomarkers Ability to Predict Heart Disease and Stroke is Limited
10. Probable Biomarkers for Squamous Cell Carcinoma
11. New Genetic Biomarkers Could Predict Coronary Heart Disease
Post Your Comments:

(Date:11/26/2015)... BOSTON, Mass. (PRWEB) , ... November 26, 2015 ... ... a thorough second medical opinion process, participated in the 61st annual Employee Benefits ... Benefit Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. ...
(Date:11/25/2015)... ... 2015 , ... As part of a global movement to ... together who want to combine talents and resources to help create sustainable communities ... The non-profit launched its first major fundraiser on November 6, 2015 at Bent ...
(Date:11/25/2015)... NV (PRWEB) , ... November 25, 2015 , ... Dr. ... patients to learn more about hair loss treatment with the Capillus272™ Pro laser therapy ... effective solution for thicker and fuller hair, without the need for surgery, prescription pills, ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology: